| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome
|
Mauge, Laetitia
|
|
2014
|
94 |
4 |
p. 713-715
|
article
|
| 2 |
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
|
Lau, I-Jun
|
|
2014
|
94 |
4 |
p. 643-649
|
article
|
| 3 |
Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen
|
Kwong, Yok-Lam
|
|
2014
|
94 |
4 |
p. 697-699
|
article
|
| 4 |
Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma
|
Johnston, Alice C.
|
|
2014
|
94 |
4 |
p. 691-692
|
article
|
| 5 |
Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience
|
Zang, Jian
|
|
2014
|
94 |
4 |
p. 583-591
|
article
|
| 6 |
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry
|
Poel, M. W. M. van der
|
|
2014
|
94 |
4 |
p. 651-661
|
article
|
| 7 |
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
|
Cherry, Mohamad
|
|
2014
|
94 |
4 |
p. 717-719
|
article
|
| 8 |
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?
|
Sánchez, L. A. Guardado
|
|
2014
|
94 |
4 |
p. 609-616
|
article
|
| 9 |
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
|
Brissot, Eolia
|
|
2014
|
94 |
4 |
p. 663-669
|
article
|
| 10 |
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
|
Font, Patricia
|
|
2014
|
94 |
4 |
p. 565-573
|
article
|
| 11 |
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy
|
Kuroda, Junya
|
|
2014
|
94 |
4 |
p. 687-689
|
article
|
| 12 |
L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage
|
Deyhim, Mohammad Reza
|
|
2014
|
94 |
4 |
p. 671-680
|
article
|
| 13 |
Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma
|
Han, Jae Joon
|
|
2014
|
94 |
4 |
p. 575-581
|
article
|
| 14 |
Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient
|
Taguchi, Masataka
|
|
2014
|
94 |
4 |
p. 693-695
|
article
|
| 15 |
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation
|
Jeong, Seong Hyun
|
|
2014
|
94 |
4 |
p. 617-625
|
article
|
| 16 |
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial
|
Wasle, Ines
|
|
2014
|
94 |
4 |
p. 593-601
|
article
|
| 17 |
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma
|
Higo, Takashi
|
|
2014
|
94 |
4 |
p. 683-685
|
article
|
| 18 |
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes
|
Oliveira, A. C.
|
|
2014
|
94 |
4 |
p. 627-632
|
article
|
| 19 |
Quality assessment of autologous haematopoietic blood progenitor cell grafting
|
Lanza, Francesco
|
|
2014
|
94 |
4 |
p. 705-706
|
article
|
| 20 |
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma
|
Czuczman, Myron S.
|
|
2015
|
94 |
4 |
p. 633-641
|
article
|
| 21 |
Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis
|
Armstrong, C.
|
|
2014
|
94 |
4 |
p. 711-712
|
article
|
| 22 |
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma
|
Hara, Masaki
|
|
2014
|
94 |
4 |
p. 603-608
|
article
|
| 23 |
Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease
|
Comont, Thibault
|
|
2014
|
94 |
4 |
p. 701-702
|
article
|
| 24 |
The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments
|
Hillis, Christopher M.
|
|
2015
|
94 |
4 |
p. 541-545
|
article
|
| 25 |
The first two cases of MYH9 disorders in Thailand: an international collaborative study
|
Sirachainan, Nongnuch
|
|
2014
|
94 |
4 |
p. 707-709
|
article
|
| 26 |
The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia
|
Cox, M. Christina
|
|
2014
|
94 |
4 |
p. 681-682
|
article
|
| 27 |
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach
|
Karthaus, Meinolf
|
|
2015
|
94 |
4 |
p. 547-556
|
article
|
| 28 |
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial
|
Röllig, Christoph
|
|
2014
|
94 |
4 |
p. 557-563
|
article
|
| 29 |
Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion
|
Wong, Hilda
|
|
2014
|
94 |
4 |
p. 703-704
|
article
|
Journal description